CALB1 and cancer: Given the growth defects of CALB1-deficient LUSC cell lines, autocrine CXCL8 signaling driving cancer cell–intrinsic growth is unlikely to compensate for this proliferative disadvantage or to explain the worse prognosis of CALB1-negative tumors.